Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1649989/000157104916020882/t1602975-10k.htm
SEC Filings
ONS Annual Reports
ONS Quarterly Reports
ONS Corporate News
Financial Exhibit
New Agreement
New Financial Obligation
Other Events
Security Holders Change
Unregistered Sales November 2018
Listing Status October 2018
Event for Officers
Financial Exhibit October 2018
Event for Officers
Financial Exhibit
Vote of Security Holders September 2018
Ending Agreement September 2018
Earnings Release
Financial Exhibit August 2018
Event for Officers
Financial Exhibit
Other Events August 2018
Bylaw Change
Financial Exhibit
New Agreement
Other Events
Security Holders Change
Unregistered Sales
Vote of Security Holders July 2018
Financial Exhibit
Other Events July 2018
Event for Officers July 2018
Financial Exhibit
New Agreement
New Financial Obligation
Other Events
Security Holders Change
Unregistered Sales
New Agreement
New Financial Obligation
Other Events
Security Holders Change
Unregistered Sales
November 2018
Listing Status
October 2018
Event for Officers
Financial Exhibit
Financial Exhibit
October 2018
Event for Officers
Financial Exhibit
Vote of Security Holders
Financial Exhibit
Vote of Security Holders
September 2018
Ending Agreement
September 2018
Earnings Release
Financial Exhibit
Financial Exhibit
August 2018
Event for Officers
Financial Exhibit
Other Events
Financial Exhibit
Other Events
August 2018
Bylaw Change
Financial Exhibit
New Agreement
Other Events
Security Holders Change
Unregistered Sales
Vote of Security Holders
Financial Exhibit
New Agreement
Other Events
Security Holders Change
Unregistered Sales
Vote of Security Holders
July 2018
Financial Exhibit
Other Events
Other Events
July 2018
Event for Officers
July 2018
Last10K.com | 10-K Annual Report Thu Dec 29 2016
Document And Entity Information - USD ($) | 12 Months Ended | ||
|---|---|---|---|
Sep. 30, 2016 | Dec. 28, 2016 | Mar. 31, 2016 | |
| Document And Entity Information [Abstract] | |||
| Entity Registrant Name | Oncobiologics, Inc. | ||
| Entity Central Index Key | 0001649989 | ||
| Trading Symbol | ons | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No | ||
| Current Fiscal Year End Date | --09-30 | ||
| Entity Filer Category | Smaller Reporting Company | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Common Stock, Shares Outstanding | 23,578,942 | ||
| Entity Public Float | $ 0 | ||
| Document Type | 10-K | ||
| Document Period End Date | Sep. 30, 2016 | ||
| Amendment Flag | false | ||
| Document Fiscal Year Focus | 2016 | ||
| Document Fiscal Period Focus | FY |
View differences made from one year to another to evaluate Oncobiologics, Inc.'s financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Oncobiologics, Inc..
Assess how Oncobiologics, Inc.'s management team is paid from their Annual Proxy
Oncobiologics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parentheticals)
Consolidated Statements Of Cash Flows (unaudited)
Consolidated Statements Of Operations (unaudited)
Consolidated Statements Of Redeemable Preferred Stock, Common Stock, Noncontrolling Interests And Stockholders' Equity (deficit) -(unaudited)
Accrued Expenses
Accrued Expenses (details)
Accrued Expenses (tables)
Basis Of Presentation And Summary Of Significant Accounting Policies
Basis Of Presentation And Summary Of Significant Accounting Policies (detail Textuals)
Basis Of Presentation And Summary Of Significant Accounting Policies (details)
Basis Of Presentation And Summary Of Significant Accounting Policies (policies)
Basis Of Presentation And Summary Of Significant Accounting Policies (tables)
Collaboration Arrangements
Collaboration Arrangements (detail Textuals)
Commitments
Commitments (detail Textuals)
Commitments (details)
Commitments (tables)
Debt
Debt (detail Textuals)
Debt (details 1)
Debt (details)
Debt (tables)
Fair Value Measurements
Fair Value Measurements (detail Textuals)
Fair Value Measurements (details 1)
Fair Value Measurements (details 2)
Fair Value Measurements (details)
Fair Value Measurements (tables)
Income Taxes
Income Taxes (detail Textuals)
Income Taxes (details 1)
Income Taxes (details 2)
Income Taxes (details 3)
Income Taxes (details)
Income Taxes (tables)
Liquidity
Liquidity (detail Textuals)
Organization And Description Of Business (detail Textuals)
Organization And Operations
Property And Equipment
Property And Equipment (detail Textuals)
Property And Equipment (details 1)
Property And Equipment (details)
Property And Equipment (tables)
Redeemable Preferred Stock, Common Stock, Noncontrolling Interests And Stockholders' Equity (deficit)
Redeemable Preferred Stock, Common Stock, Noncontrolling Interests And Stockholders' Equity (deficit) (detail Textuals 1)
Redeemable Preferred Stock, Common Stock, Noncontrolling Interests And Stockholders' Equity (deficit) (detail Textuals)
Related-party Transactions
Related-party Transactions (detail Textuals)
Stock Based Compensation (detail Textuals 1)
Stock Based Compensation (detail Textuals 2)
Stock Based Compensation (detail Textuals 3)
Stock Based Compensation (detail Textuals)
Stock Based Compensation (details 1)
Stock Based Compensation (details 2)
Stock Based Compensation (details 3)
Stock Based Compensation (details 4)
Stock Based Compensation (details)
Stock-based Compensation
Stock-based Compensation (tables)
Stockholder Notes
Stockholder Notes (detail Textuals)
Stockholder Notes (details)
Stockholder Notes (tables)
Subsequent Events
Subsequent Events (detail Textuals)
Material Contracts, Statements, Certifications & more
Oncobiologics, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ONS
CIK: 1649989
Form Type: 10-K Annual Report
Accession Number: 0001571049-16-020882
Submitted to the SEC: Thu Dec 29 2016 4:17:10 PM EST
Accepted by the SEC: Thu Dec 29 2016
Period: Friday, September 30, 2016
Industry: Biological Products No Disgnostic Substances
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/ons/0001571049-16-020882.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...